
Ammar Bhatti DO
@ammarwb
Aspiring Cardiologist | Medical education, POCUS & 🏀fanatic| Lahey IM Chief Resident @bethisraellahey | Future @laheycardiology🫀fellow | DO @ UNECOM 2021
ID: 1494826045295501312
19-02-2022 00:08:13
64 Tweet
134 Takipçi
312 Takip Edilen

A recent study by @PennThalheimer Marielle Scherrer-Crosbie et al. sought to determine whether SGLT2i use is associated with a lower incidence of CTRCD in patients w/ #T2DM & #cancer. Learn more 👉 spr.ly/6016qlXbM #cardiomyopathy #cardiooncology


New JACC Journals #JACCHF In patients with #T2DM, ⬆️ #BMI & #HFpEF ➡️ #GLP1 agonists provide incremental benefit in addition to #SGLT2i with ⬇️ in: ▪️HF exacerbation ▪️All cause hospitalization ▪️Atrial arrhythmias ▪️Pulmonary HTN ▪️AKI DOI: 10.1016/j.jchf.2024.07.006


New #JACCHF 📄: bit.ly/40xnSB9 In patients w/ #Obesity, #T2DM & #HFpEF➡️#GLP1 agonists provide incremental benefits in addition to #SGLT2i w/ reduction in: 🔸HF exacerbation 🔸All-cause 🏥 🔸Atrial arrhythmias 🔸AKI 🔸Pulmonary #HTN Rushin Patel MD Sarju Ganatra, MD, FACC


Thrilled to have matched a fantastic group Lahey Cardiology for Cardiology Fellowship 2025! Ammar Bhatti DO Brandon Temel Sriram Garikapati Pawan Daga Looking forward to working with you!


The ‘Match’ day excitement!! We are delighted that you chose us for your training Lahey Hospital Beth Israel Lahey Health Inbar McCarthy MD FACC Sarju Ganatra, MD, FACC Saurabh S Dani, MD, MSc sachin shah Michael Levy MD MPH @ArjunMajithiaMD Gautam Gadey Frederic Resnic

Happy to share our Invited Editorial with Mohamed Dabour Anne Blaes and Dharini Ramu SGLT2 Inhibitors in Mitigating Cancer Therapy-Related Cardiac Dysfunct... sciencedirect.com/science/articl…



Publication alert: GLP-1RAs improve HF outcomes in non-obese diabetic HFpEF patients #Cardiology #research Deeply grateful to Sarju Ganatra, MD, FACC and Saurabh S Dani, MD, MSc for their exceptional mentorship and guidance throughout this research journey. Thank you for this opportunity.🙏🙏🙏

In this #JACCCardioOnc study, Dr. Ammar Bhatti DO, et al highlight that #SGLT2 inhibitors 📉 the risk of CTRCD in pts w/ #T2DM & cancer, as well as lower #heartfailure exacerbations, mortality, & 🏥 jacc.org/doi/10.1016/j.… #CardioOncology #SGLT2i Anita Deswal Ana Barac, MD, PhD, FACC, FAHA


I had a fantastic time recording podcast on Heart Disease in South Asians with Rahul Menon of Indian Diaspora. Listen to this candid but critical conversation here. Special thanks to Khurram Nasir Alka Kanaya Jaideep Anandita Agarwala Kulkarni, MD FACC Priyanka Satish Pradeep Natarajan @RomitB_MD


“Excited to share our latest editorial published in Circulation - Our study highlights T1 mapping as a novel marker for heart failure progression in hypertrophic cardiomyopathy (HCM). Ethan Rowin JAHA AHA Science



Takeaways from #ACC2025. Late breaking trials - take home points American College of Cardiology 1. WARRIOR Trial : Intensive medical therapy did not significantly impact the rate of serious cardiovascular events at five years in women with suspected ischemia with nonobstructive coronary arteries

And the journey begins for these fantastic gentlemen! We welcome you Lahey Cardiology and look forward to your all round training and transformation as able cardiologists!




Proud of our fellows and faculty! Looking forward to continuing recruiting fantastic class again this year! Come join us Lahey Hospital Beth Israel Lahey Health Lahey Cardiology